Clinical implications and prognostic value of single and combined biomarkers in endometrial carcinoma

被引:0
|
作者
Li Mingzhu [1 ]
Zhao Lijun [1 ]
Shen Danhua [1 ]
Li Xiaoping [1 ]
Wang Jianliu [1 ]
Wei Lihui [1 ]
机构
[1] Department of Obstetrics and Gynecology, Peking University People’s Hospital
基金
中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
R737.33 [子宫肿瘤];
学科分类号
摘要
Background Endometrial carcinoma is one of the most common gynecological cancers and the incidence has been increasing. This study was to identify the relationship of estrogen receptor(ER), progestrone receptor(PR), P53 protein, Ki-67 and phosphatase and tensin homolog deleted on chromosome ten(PTEN) with endometrial carcinoma, the assessment of these biomarkers and their association with clinicopathological parameters was performed.Methods A total of 198 cases of primary endometrial carcinoma were investigated for ER, PR, Ki-67, P53, and PTEN antigens by immunohistochemical methods. The association of these markers with age, menopause status, histological type, FIGO stage, grading, depth of invasion, lymph node involvement and serum tumor marker was examined.Results The percentages of Ki-67- and P53-negative endometrial tumors were significantly higher in ER-positive compared with ER-negative tumors(both P=0.000). The same trend was evident with PR status. The percentage of PTEN-positive tumors was significantly higher in PR-positive compared with PR-negative tumors(P=0.021), but was no difference in tumors with different ER status. There was no clear association between PTEN positivity and clinicopathological parameters except more relevance with endometrioid histotype(P=0.013). There was a statistically significant difference in the distribution of the different combined biological factors examined in disease-free survival.Conclusions ER and PR status were significant predictors with staging, grading and recurrence. P53 and Ki-67 expression were inversely correlated with both ER and PR expression and have more aggressive clinicopathological features. PTEN expression was inversely correlated with PR expression but not with ER expression. The combined type of ER+PR+P53-PTEN+ was in the majority in endometrial cancer and seemed to be related to better clinical outcome. The combination of ER-PR-P53+PTEN- represented the worst disease-free survival and was strongly associated with poorest survival rate.
引用
收藏
页码:1459 / 1463
相关论文
共 50 条
  • [21] Prognostic biomarkers in endometrial adenocarcinoma
    Stanescu, Anca Daniela
    Nistor, Ileana
    Poteca, Anca Gabriela
    Ditescu, Damian
    Comanescu, Maria
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2014, 55 (04): : 1339 - 1344
  • [22] Prognostic value of the presence of serous endometrial intraepithelial carcinoma in uterine serous carcinoma
    Comert, Gunsu Kimyon
    Ersak, Burak
    Tokalioglu, Abdurrahman Alp
    Celik, Fatih
    Ersak, Duygu
    Ayhan, Sevgi
    Kilic, Fatih
    Turkmen, Osman
    Tekin, Ozlem Moraloglu
    Turan, Taner
    CUKUROVA MEDICAL JOURNAL, 2024, 49 (02): : 239 - 247
  • [23] Prognostic value and clinical significance of IL-33 expression in patients with uterine corpus endometrial carcinoma
    Liu, Yuqi
    Wang, Han
    Zhao, Shihan
    Wang, Zhenjiang
    Yang, Lijuan
    Zhang, Jihong
    Hou, Qinlong
    Xiao, Zishen
    Wang, Pengmin
    Liu, Yanbo
    CYTOKINE, 2025, 185
  • [24] Prognostic value of biomarkers in primary small cell carcinoma of the esophagus
    Wang, Yan
    Che, Guowei
    THORACIC CANCER, 2020, 11 (05) : 1119 - 1120
  • [25] Identification of potential biomarkers in ovarian carcinoma and an evaluation of their prognostic value
    Cai, Junyan
    Qiu, Jiayi
    Wang, Hongliang
    Sun, Jiacheng
    Ji, Yanan
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (18)
  • [26] Clinical Implications of Genomic Loss of Heterozygosity in Endometrial Carcinoma
    Bustamante, Bethany
    Sinha, Risha
    Rice, Briana
    Nizam, Aaron
    Shan, Weiwei
    Goldberg, Gary L.
    John, Veena
    Lin, Doug, I
    Danziger, Natalie
    Pavlick, Dean C.
    Elvin, Julia A.
    Frimer, Marina
    JCO PRECISION ONCOLOGY, 2021, 5 : 1013 - 1023
  • [27] The prognostic value of clinical factors in vulvar carcinoma
    Kouvaris, J
    Kouloulias, V
    Sykiotis, C
    Kreatsas, G
    Vlahos, L
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S280 - S280
  • [28] Metabolomic and proteomic approaches for discovery of diagnostic and prognostic biomarkers for endometrial carcinoma - BioEndoCar
    Hafner, E.
    Smrkolj, S.
    Pirs, B.
    Romano, A.
    Werner, E.
    Semczuk, A.
    Kaminska, A.
    Adamiak-Godlewska, A.
    Fishman, D.
    Vilo, J.
    Lowy, C.
    Schroeder, C.
    Tokarz, J.
    Adamski, J.
    Weinberger, V.
    Bednarikova, M.
    Vinklerova, P.
    Ferrero, S.
    Barra, F.
    Takac, I.
    Knez, J.
    Sobocan, M.
    Rizner, T. Lanisnik
    FEBS OPEN BIO, 2021, 11 : 321 - 322
  • [29] Glycosyltransferase-related prognostic and diagnostic biomarkers of uterine corpus endometrial carcinoma
    Wu, Jiaoqi
    Zhou, Xiaozhu
    Ren, Jie
    Zhang, Zhen
    Ju, Haoyu
    Diao, Xiaoqi
    Jiang, Shuyi
    Zhang, Jing
    COMPUTERS IN BIOLOGY AND MEDICINE, 2023, 163
  • [30] Impact of endometrial carcinoma histotype on the prognostic value of the TCGA molecular subgroups
    Travaglino, Antonio
    Raffone, Antonio
    Stradella, Cristina
    Esposito, Rosanna
    Moretta, Paola
    Gallo, Cinzia
    Orlandi, Giuliana
    Insabato, Luigi
    Zullo, Fulvio
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2020, 301 (06) : 1355 - 1363